B12 & MIC Injections Essential for metabolism and fat breakdown, promoting sustained energy and body composition improvements
For safety reasons, oral semaglutide is not recommended for people with a personal or family history of medullary thyroid cancer or certain genetic endocrine disorders
Key factors include baseline body weight, adherence to reduced-calorie diet and increased physical activity, presence of type 2 diabetes (which typically results in less weight loss), concurrent medications affecting appetite or metabolism, and individual tolerance to gastrointestinal side effects
Your provider starts you low, raises the dose gradually, and checks in monthly so anything uncomfortable is addressed early
Patients interpret same dose as no change. But the pharmacology tells a different story
Second Nature remains an NHS-commissioned provider for weight management and diabetes prevention